Immunological Research
Process Provides Ability to Screen Cancer Patients for Anti-Tumor Antibodies
Published in Cancer Weekly, July 24th, 1995
The isolation of antibodies that react selectively with human tumor cells has been a major focus of cancer immunology. This has the potential for important applications by targeting diagnostic and therapeutic agents.
To date, no process has succeeded in combining ease, efficiency, and success. Ziaohong Cai et al. constructed a system that maps fusion-phage libraries expressing single-chain Fv antibodies ("Anti-Melanoma Antibodies from Melanoma Patients Immunized with Genetically Modified Autologous Tumor Cells: Selection of Specific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-07-24)
More Articles from Cancer Weekly
- Cancer Vaccines
Human Carcinoembryonic Antigen as Second-Generation Immunotherapy - Breast Cancer/Risk
Hormone Replacement Therapy Not Linked to Increased Risk - Diagnostics
E6/E7 Transcripts of HPV-16 Useful as Diagnostic Tool of Micrometastasis - Gene Discovery
Blocking Cancer Cells' "Sweet Tooth" May Stop or Kill Malignant Tumors - Immunological Research
Eliminating Factors Necessary for Tumor Growth Stimulates Rejection - Immunotherapy
MAGE Gene Expression in Breast Cancer and How It Relates to Immunotherapy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
